Virally mediated cervical cancer in the iatrogenically immunocompromised: Applications for psychoneuroimmunology

Brain, Behavior, and Immunity

Volumn 21, Issue 6, 2007, Pages 758-766

  Jensen, Sally E ^a   Lehman, Brandy ^a,b   Antoni, Michael H ^c   Pereira, Deidre B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Department of Biology   (United States)

Author keywords

Cervical cancer; Human papillomavirus (HPV); Psychoneuroimmunology (PNI); Renal transplant

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; T LYMPHOCYTE ANTIBODY; TACROLIMUS;

CANCER RISK; CARCINOGENESIS; COMORBIDITY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; SOCIAL PSYCHOLOGY; UTERINE CERVIX CANCER; VERRUCA VULGARIS; VIRUS INFECTION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; FEMALE; HIV SEROPOSITIVITY; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; PSYCHOLOGY; PSYCHONEUROIMMUNOLOGY; UTERINE CERVICAL NEOPLASMS;

EID: 34347273404     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2007.01.003     Document Type: Review

References (55)

1. Alcocer-Gonzalez J.M., Berumen J., Tamez-Guerra R., Bermudez-Morales V., Peralta-Zaragoza O., Hernandez-Pando R., et al. In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells. Viral. Immunol. 19 (2006) 483-491
2. American College of Obstetrics and Gynecology (2003). Cervical Cancer Screening: Testing Can Start Later and Occur Less Often Under New ACOG Recommendations. Accessed 5-19-05. Available from: http://www.acog.org/from_home/publications/press_releases/nr07-31-03-1.cfm.
3. Bai L., Wei L., Wang J., Li X., and He P. Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells. Int. J. Gynecol. Cancer 16 (2006) 718-729
4. Baines L.S., Joseph J.T., and Jindal R.M. Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants. Kidney Int. 65 (2004) 1937-1942
5. Bais A.G., Beckman I., Lindemans J., Ewing P.C., Meijer C.J., Snijders P.J., et al. A shift to peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J. Clin. Pathol. 58 (2005) 1096-1100
6. Baseman J.G., and Koutsky L.A. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32S (2005) S16-S24
7. Bosch F.X., and de Sanjose S. Human papillomavirus and cervical cancer-burden and assessment of causality. J. Nat. Cancer Inst. Monogr. 31 (2003) 3-13
8. Bouwes Bavinck J.N., and Berkhout R.J.M. HPV infections and immunosuppression. Clinics Derm. 15 (1997) 427-437
9. Brown M.R., Noffsinger A., First M.R., Penn I., and Husseinzadeh N. HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients. Gynecol. Oncol. 79 (2000) 220-224
10. Buell J.F., Gross T.G., and Woodle E.S. Malignancy after transplantation. Transplantation 80 (2005) S254-S264
11. Byrnes D.M., Antoni M.H., Goodkin K., Efantis-Potter J., Asthana D., Simon T., Munajj J., Ironson G., and Fletcher M. Stressful events, pessimism, natural killer cell cytotoxicity, and cytotoxic/suppressor T cells in HIV+ Black women at risk for cervical cancer. Psychosom. Med. 60 (1998) 714-722
12. Centers for Disease Control and Prevention (2004). Report to Congress: Prevention of genital Human Papillomavirus infection.
13. Christensen A.J., and Ehlers S.L. Psychological factors in end-stage renal disease: An emerging context for behavioral medicine. J. Consult. Clin. Psychol. 70 (2002) 712-724
14. Coker A.L., Bond S., Madeleine M.M., Luchok K., and Pirisi L. Psychosocial stress and cervical neoplasia risk. Psychosom. Med. 65 (2003) 644-651
15. Coleman N., et al. Immunological events in regressing genital warts. Am. J. Clin. Pathol. 102 (1994) 768-774
16. Cruess D.G., Douglas S.D., Petitto J.M., Have T.T., Gettes D., Dube B., et al. Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women. Am. J. Psychiatry 162 (2005) 2125-2130
17. Dell G., and Gaston K. Human papillomaviruses and their role in cervical cancer. Cell Mol. Life Sci. 58 (2001) 1923-1942
18. Dimitrov S., Lange T., Tieken S., Fehm H.L., and Born J. Sleep associated regulation of T helper 1/T helper 2 cytokine balance in humans. Brain, Behav., Immunol. 18 (2004) 341-348
19. Eryilmaz M.M., Ozdemir C., Yurtman F., Cilli A., and Karaman T. Quality of sleep and quality of life in renal transplantation patients. Transplant Proc. 37 (2005) 2072-2076
20. Evans D.L., Ten Have T.R., Douglas S.D., Gettes D.R., Morrison M., Chiappini M.S., et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am. J. Psychiatry 159 (2002) 1752-1759
21. Fairley C.K., Chen S., Tabrizi S.N., McNeil J., Becker G., Walker R., and Atkins R.C. Prevalence of HPV DNA in cervical specimens in women with renal transplants: a comparison with dialysis-dependent patients and patients with renal impairment. Nephrol., Dial., Transplant 9 (1994) 416-420
22. Fang C.Y., Miller S.M., Mills M., Mangan C.E., Belch R., Campbell D.E., and Doublas S.D. The effects of avoidance on cytotoxic/suppressor T cells in women with cervical lesions. Psychooncology 12 (2003) 590-598
23. Guimaraes Concalves M.A., and Donadi E.A. Immune cellular response to HPV: Current concepts. Braz. J. Infect. Dis. 8 (2004) 1-9
24. Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., et al. Efficacy of a bivalent L1virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 364 (2004) 1757-1765
25. Ho G.Y., Bierman R., Beardsley L., Chang C.J., and Burk R.D. Natural history of cervicovaginal human papillomavirus infection in young women. N. Engl. J. Med. 338 (1998) 423-428
26. International Agency for Research on Cancer (1995). IARC monographs on the evaluation of carcinogenic risks to humans. Volume 64. Human papillomaviruses. Lyons, France.
27. Kasiske B.L., Snyder J.J., Gilbertson D.T., and Wang C. Cancer after kidney transplantation in the United States. Am. J. Transplant. 4 (2004) 905-913
28. Klapheke M.M. Transplantation psychoneuroimmunology: building hypotheses. Med. Hypoth. 54 (2000) 969-978
29. Lacey C.J. Therapy for genital human papillomavirus-related disease. J. Clin. Virol. 32 (2005) S82-S90
30. Maiman M., Fructher R.G., Serur E., Levine P.A., Arrastia C.D., and Sedlis A. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet. Gynecol. 82 (1993) 170-174
31. Maiman M., Fruchter R.G., Clark M., Arrastia C.D., Matthews R., and Gates E.J. Cervical cancer as an AIDS-defining illness. Obstet. Gynecol. 65 (1997) 348-356
32. Monnier-Benoit S., Mauny F., Riethmuller D., Guerrini J.S., Capilna M., Felix S., Seilles E., et al. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol. Oncol. 102 (2006) 22-31
33. Moons P., Vanrenterghem Y., Van Hooff J.P., Squifflet J.P., Margodt D., Mullens M., et al. Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: A multicentre study. Transpl. Int. 16 (2003) 653-664
34. Moscicki A.B., Schiffman M., Kjaer S., and Villa L.L. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 24S3 (2006) S42-S51
35. Muehrer R.J., and Becker B.N. Life after transplantation: new transitions in quality of life and psychological distress. Semin. Dial. 18 (2005) 124-131
36. Muñoz N., Bosch X., de Sanjose S., Herrero R., Catellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348 (2003) 518-527
37. Myers E.R., McCrory D.C., Nanda K., Bastian L., and Matchar D.B. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am. J. Epidemiol. 151 (2000) 1158-1171
38. Organ Procurement and Transplant Network [OPTN]. (2005). Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2004. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI.
39. Ozsaran A.A., Ates T., Dikmen Y., Zeytinoglu A., Terek C., Erhan Y., Ozacar T., et al. Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy. Eur. J. Gyn. Oncol. 20 (1999) 127-130
40. Palefsky J.M., and Holly E.A. Chapter 6: Immunosuppression and co-infection with HIV. J. Nat. Cancer Inst. Monogr. 31 (2003) 41-46
41. Palefsky J.M., Minkoff H., Kalish L.A., Levine A., Sacks H.S., Garcia P., et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV negative women. J. Nat. Cancer Inst. 91 (1999) 226-236
42. Penn I. Cancers of the anogenital region in renal transplant recipients: Analysis of 65 cases. Cancer 58 (1986) 616-711
43. Penn I. Post-transplant malignancy: The role of immunosuppression. Drug Saf. 23 (2000) 101-113
44. Pereira D.B., Antoni M.H., Danielson A., Simon T., Efantis-Potter J., Carver C.S., Duran R.E.F., Ironson G., Klimas N., and O'Sullivan M. Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom. Med. 65 (2003) 427-434
45. Pereira D., Antoni M., Fletcher M.A., and O'Sullivan M.J. Cognitive behavioral stress management (CBSM) effects on regression of cervical dysplasia among HIV+ women [Abstract]. Psychosom. Med. 67 1 (2005) 1152
46. Sabbatini M., Crispo A., Pisani A., Gallo R., Cianciaruso B., Fuiano G., Federico S., and Andreucci V.E. Sleep quality in renal transplant patients: a never investigated problem. Nephrol., Dial., Transplant. 20 (2005) 194-198
47. Satam N.M., Suraiya J.N., and Nadkarni J.J. Natural killer and antibody-dependent cellular cytotoxicity in cervical carcinoma patients. Cancer Immunol. Immunother. 23 (1986) 56-59
48. Savard J., Miller S.M., Mills M., O'Leary A., Harding H., Douglas S.D., et al. Association between subjective sleep quality and depression on immunocompetence in low-income women at risk for cervical cancer. Psychosom. Med. 61 (1999) 496-507
49. Scales D.C., and Granton J.T. The transplant patient. In: Hall J.B., Schmidt G.A., and Wood L.D.H. (Eds). Principles of Critical Care Third Edition (2005), McGraw Hill, New York 1355-1374
50. Scott M., Stites D.P., and Moscicki M.B. Th1 cytokine patterns in cervical human papillomavirus infection. Clin. Diagn. Lab. Immunol. 6 (1999) 751-755
51. Sparano A., Lathers D.M., Achille N., Petruzzelli G.J., and Young M.R. Modulation of Th1 and Th2 cytokine profiles and their association with advanced head and neck squamous cell carcinoma. Otolaryng. Head Neck Surg. 131 (2004) 573-576
52. Tam L.A., Chan A.Y.K., Chan P.K.S., Chang A.R., and Li E.K. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: Association with human papillomavirus infection. Arthritis & Rheum 50 (2004) 3619-3625
53. Tiersma E.S., van der Lee M.L., Garssen B., Peters A.A., Visser A.P., Fleuren G.J., et al. Psychosocial factors and the course of cervical intra-epithelial neoplasia: a prospective study. Gynecol. Oncol. 97 (2005) 879-886
54. United Network for Organ Sharing [UNOS]. (2005, September 20). Medications: Protecting your transplant. Retrieved June 1, 2006, from http://www.transplantliving.org/afterthetransplant/typesofsuppressants.aspx.
55. Waller J., McCaffery K.J., Forrest S., and Wardle J. Human papillomavirus and cervical cancer: issues for biobehavioral and psychosocial research. Ann. Behav. Med. 27 (2004) 68-79